Login Register Cart 0
Generic placeholder image

Current Medical Imaging

Editor-in-Chief

ISSN (Print): 1573-4056
ISSN (Online): 1875-6603

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Role of Magnetic Resonance Imaging in the Diagnosis of Placenta Accreta

Author(s): Lei Niu, Wen Cui, Chunxia Zhu, Xiaoning Lu, Yongkang Wang and Feng Wang*

Volume 20, 2024

Published on: 10 August, 2023

Article ID: e270623218308 Pages: 7

DOI: 10.2174/1573405620666230627112729

Price: $65

Abstract

Introduction: To analyze the value of magnetic resonance imaging (MRI) in suspicious cases for prenatal detection of placenta accreta (PA).

Materials and Methods: A total of 50 placental MRI exams performed on a 1.5T scanner were retrospectively reviewed by two radiologists in consensus. HASTE (half- Fourier acquisition single-shot turbo spin echo)and True-FISP (true fast imaging with steady-state precession) sequences were acquired. Findings from MRI were compared with the final diagnosis, which was determined by clinical findings at delivery and pathological examination of specimens.

Results: Of 50 pregnant women in the analysis, 33 required cesarean hysterectomy, and 17 underwent cesarean delivery.MRI signs such as myometrial thinning, loss of T2 hypointense interface(loss of retroplacental clear space on US), heterogenous intraplacental sign, and intraplacental T2 dark bands were more likely to be seen in this group.

In this group, the cases that were finally clinically and pathologically confirmed were 12, 16, and 22 cases of placenta accreta vera, placenta increta, and placenta percreta respectively.

Conclusion: MRI is particularly useful in cases where US is inconclusive and to assess the extent to which the placenta penetrates the uterine serosa and invades outward into surrounding tissues.MRI has become a routine examination for patients with suspected PA in clinical practice.

[1]
Silver RM, Branch DW. Placenta accreta spectrum. N Engl J Med 2018; 378(16): 1529-36.
[http://dx.doi.org/10.1056/NEJMcp1709324] [PMID: 29669225]
[2]
Marcellin L, Delorme P, Bonnet MP, et al. Placenta percreta is associated with more frequent severe maternal morbidity than placenta accreta. Am J Obstet Gynecol 2018; 219(2): 193.e1-9.
[http://dx.doi.org/10.1016/j.ajog.2018.04.049] [PMID: 29733839]
[3]
Jing L, Wei G, Mengfan S, Yanyan H. Effect of site of placentation on pregnancy outcomes in patients with placenta previa. PLoS One 2018; 13(7): e0200252.
[http://dx.doi.org/10.1371/journal.pone.0200252] [PMID: 30016336]
[4]
Baldwin HJ, Patterson JA, Nippita TA, et al. Antecedents of abnormally invasiveplacenta in primiparous women: Risk associatedwith gynecologic procedures. Obstet Gynecol 2018; 131(2): 227-33.
[http://dx.doi.org/10.1097/AOG.0000000000002434] [PMID: 29324602]
[5]
Melcer Y, Jauniaux E, Maymon S, et al. Impact of targeted scanning protocols on perinatal outcomes in pregnancies at risk of placenta accreta spectrum or vasa previa. Am J Obstet Gynecol 2018; 218(4): 443.e1-8.
[http://dx.doi.org/10.1016/j.ajog.2018.01.017] [PMID: 29353034]
[6]
Carusi DA. The placenta accreta spectrum: Epidemiology and risk factors. Clin Obstet Gynecol 2018; 61(4): 733-42.
[http://dx.doi.org/10.1097/GRF.0000000000000391] [PMID: 30204619]
[7]
Duzyj CM, Cooper A, Mhatre M, et al. Placenta accreta: A spectrum of predictable risk, diagnosis, and morbidity. Am J Perinatol 2019; 36(10): 1031-8.
[http://dx.doi.org/10.1055/s-0038-1676111] [PMID: 30500963]
[8]
World Medical Association. World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA 2013; 310(20): 2191-4.
[http://dx.doi.org/10.1001/jama.2013.281053] [PMID: 24141714]
[9]
Jauniaux E, Hussein AM, Fox KA, Collins SL. New evidence-based diagnostic and management strategies for placenta accreta spectrum disorders. Best Pract Res Clin Obstet Gynaecol 2019; 61(4): 75-88.
[http://dx.doi.org/10.1016/j.bpobgyn.2019.04.006] [PMID: 31126811]
[10]
Jauniaux E, Collins S, Burton GJ. Placenta accreta spectrum: Pathophysiology and evidence-based anatomy for prenatal ultrasound imaging. Am J Obstet Gynecol 2018; 218(1): 75-87.
[http://dx.doi.org/10.1016/j.ajog.2017.05.067] [PMID: 28599899]
[11]
Durukan H, Durukan ÖB, Yazıcı FG. Placenta accreta spectrum disorder: A comparison between fertility-sparing techniques and hysterectomy. J Obstet Gynaecol 2021; 41(3): 353-9.
[http://dx.doi.org/10.1080/01443615.2020.1755629] [PMID: 32500820]
[12]
D’Antonio F, Timor-Tritsch IE, Palacios-Jaraquemada J, et al. First‐trimester detection of abnormally invasive placenta in high‐risk women: Systematic review and meta‐analysis. Ultrasound Obstet Gynecol 2018; 51(2): 176-83.
[http://dx.doi.org/10.1002/uog.18840] [PMID: 28833750]
[13]
Jitsumori M, Matsuzaki S, Endo M, et al. Obstetric outcomes of pregnancyafter uterine artery embolization. Int J Womens Health 2020; 12(3): 151-8.
[http://dx.doi.org/10.2147/IJWH.S236443] [PMID: 32184677]
[14]
Jauniaux E, Ayres-de-Campos D, Langhoff-Roos J, et al. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet 2019; 146(1): 20-4.
[http://dx.doi.org/10.1002/ijgo.12761] [PMID: 31173360]
[15]
Collins SL, Alemdar B, van Beekhuizen HJ, et al. Evidence-based guidelines for the management of abnormally invasive placenta: Recommendations from the International Society for Abnormally Invasive Placenta. Am J Obstet Gynecol 2019; 220(6): 511-26.
[http://dx.doi.org/10.1016/j.ajog.2019.02.054] [PMID: 30849356]
[16]
American College of Obstetricians and Gynecologists. Society forMaternal-Fetal Medicine. Obstetric care consensus no. 7: Placentaaccreta spectrum. Obstet Gynecol 2018; 132(6): e259-75.
[http://dx.doi.org/10.1097/AOG.0000000000002983] [PMID: 30461695]
[17]
Pala Ş, Atilgan R, Başpınar M, et al. Comparison of results of Bakri balloon tamponade and caesarean hysterectomy in management of placenta accreta and increta: A retrospective study. J Obstet Gynaecol 2018; 38(2): 194-9.
[http://dx.doi.org/10.1080/01443615.2017.1340440] [PMID: 28903630]
[18]
Zaghal AA, Hussain HK, Berjawi GA. MRI evaluation of the placenta from normal variants to abnormalities of implantation and malignancies. J Magn Reson Imaging 2019; 50(6): 1702-17.
[http://dx.doi.org/10.1002/jmri.26764] [PMID: 31102327]
[19]
Fadl S, Moshiri M, Fligner CL, Katz DS, Dighe M. Placental imaging: Normal appearance with review of pathologic findings. Radiographics 2017; 37(3): 979-98.
[http://dx.doi.org/10.1148/rg.2017160155] [PMID: 28493802]
[20]
Kilcoyne A, Shenoy-Bhangle AS, Roberts DJ, Sisodia RC, Gervais DA, Lee SI. MRI of placenta accreta, placenta increta, and placenta percreta: Pearls and pitfalls. AJR Am J Roentgenol 2017; 208(1): 214-21.
[http://dx.doi.org/10.2214/AJR.16.16281] [PMID: 27762597]
[21]
Jha P, Pōder L, Bourgioti C, et al. Society of Abdominal Radiology (SAR) and European Society of Urogenital Radiology (ESUR) joint consensus statement for MR imaging of placenta accreta spectrum disorders. Eur Radiol 2020; 30(5): 2604-15.
[http://dx.doi.org/10.1007/s00330-019-06617-7] [PMID: 32040730]
[22]
Chen X, Shan R, Zhao L, et al. Invasive placenta previa: Placental bulge with distorted uterine outline and uterine serosal hypervascularity at 1.5T MRI – useful features for differentiating placenta percreta from placenta accreta. Eur Radiol 2018; 28(2): 708-17.
[http://dx.doi.org/10.1007/s00330-017-4980-z] [PMID: 28770405]
[23]
Jain C. ACOG Committee Opinion No. 723: Guidelines for diagnostic imaging during pregnancy and lactation. Obstet Gynecol 2019; 133(1): 186.
[http://dx.doi.org/10.1097/AOG.0000000000003049] [PMID: 30575654]
[24]
Iacovelli A, Liberati M, Khalil A, et al. Risk factors for abnormally invasive placenta: A systematic review and meta-analysis. J Matern Fetal Neonatal Med 2020; 33(3): 471-81.
[http://dx.doi.org/10.1080/14767058.2018.1493453] [PMID: 29938551]
[25]
Sannananja B, Ellermeier A, Hippe DS, et al. Utility of diffusion-weighted MR imaging in the diagnosis of placenta accreta spectrum abnormality. Abdom Radiol 2018; 43(11): 3147-56.
[http://dx.doi.org/10.1007/s00261-018-1599-8] [PMID: 29666952]
[26]
Ingram E, Morris D, Naish J, Myers J, Johnstone E. MR imaging measurementsof altered placental oxygenation in pregnancies complicatedby fetal growth restriction. Radiology 2017; 285(3): 953-60.
[http://dx.doi.org/10.1148/radiol.2017162385] [PMID: 28708473]
[27]
Sun H, Qu H, Chen L, et al. Identification of suspicious invasive placentation based on clinical MRI data using textural features and automated machine learning. Eur Radiol 2019; 29(11): 6152-62.
[http://dx.doi.org/10.1007/s00330-019-06372-9] [PMID: 31444599]
[28]
Bao Y, Pang Y, Sun Z, Li Q, Tang D, Xia L. Functional diagnosis of placenta accreta by intravoxel incoherent motion model diffusion-weighted imaging. Eur Radiol 2021; 31(2): 740-8.
[http://dx.doi.org/10.1007/s00330-020-07200-1] [PMID: 32862290]
[29]
Yan G, Liao Y, Li K, et al. Diffusion MRI based myometrium tractography for detection of placenta accreta spectrum disorder. J Magn Reson Imaging 2022; 55(1): 255-64.
[http://dx.doi.org/10.1002/jmri.27794] [PMID: 34155718]
[30]
Jauniaux E, Bhide A, Kennedy A, Woodward P, Hubinont C, Collins S. FIGO consensus guidelines on placenta accreta spectrum disorders: Prenatal diagnosis and screening. Int J Gynaecol Obstet 2018; 140(3): 274-80.
[http://dx.doi.org/10.1002/ijgo.12408] [PMID: 29405319]
[31]
Kapoor H, Hanaoka M, Dawkins A, Khurana A. Review of MRI imaging for placenta accreta spectrum: Pathophysiologic insights, imaging signs, and recent developments. Placenta 2021; 104(1): 31-9.
[http://dx.doi.org/10.1016/j.placenta.2020.11.004] [PMID: 33238233]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy